Patents by Inventor Elena KAGAN

Elena KAGAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11957645
    Abstract: The present invention provides a method for safe and efficacious administration of esketamine.
    Type: Grant
    Filed: March 30, 2023
    Date of Patent: April 16, 2024
    Assignee: CLEXIO BIOSCIENCES LTD.
    Inventors: Elena Kagan, Gina Pastino
  • Publication number: 20240091174
    Abstract: The present invention provides a method for safe and efficacious administration of esketamine.
    Type: Application
    Filed: November 22, 2023
    Publication date: March 21, 2024
    Inventors: Elena Kagan, Gina Pastino
  • Publication number: 20240074992
    Abstract: The present invention provides a method for safe and efficacious administration of esketamine.
    Type: Application
    Filed: November 14, 2023
    Publication date: March 7, 2024
    Inventors: Elena Kagan, Gina Pastino
  • Publication number: 20240074991
    Abstract: The present invention provides a method for safe and efficacious administration of esketamine.
    Type: Application
    Filed: November 8, 2023
    Publication date: March 7, 2024
    Inventors: Elena KAGAN, Gina PASTINO
  • Patent number: 11865088
    Abstract: The present invention provides a method for safe and efficacious administration of esketamine.
    Type: Grant
    Filed: October 4, 2019
    Date of Patent: January 9, 2024
    Assignee: CLEXIO BIOSCIENCES LTD.
    Inventors: Elena Kagan, Gina Pastino
  • Publication number: 20230233487
    Abstract: The present invention provides a method for safe and efficacious administration of esketamine.
    Type: Application
    Filed: March 30, 2023
    Publication date: July 27, 2023
    Inventors: Elena KAGAN, Gina PASTINO
  • Publication number: 20220125742
    Abstract: The present invention provides a method for safe and efficacious administration of esketamine.
    Type: Application
    Filed: January 10, 2022
    Publication date: April 28, 2022
    Inventors: Elena Kagan, Gina Pastino
  • Patent number: 11253487
    Abstract: The present invention provides a method for safe and efficacious administration of esketamine.
    Type: Grant
    Filed: April 13, 2021
    Date of Patent: February 22, 2022
    Assignee: CLEXIO BIOSCIENCES LTD.
    Inventors: Elena Kagan, Gina Pastino
  • Publication number: 20210378989
    Abstract: The present invention provides a dosage regimen for safe and efficacious administration of esketamine and rapid-acting antidepressants in the treatment of major depressive disorder (MDD).
    Type: Application
    Filed: October 11, 2019
    Publication date: December 9, 2021
    Inventor: Elena KAGAN
  • Publication number: 20210228505
    Abstract: The present invention provides a method for safe and efficacious administration of esketamine.
    Type: Application
    Filed: April 13, 2021
    Publication date: July 29, 2021
    Inventors: Elena Kagan, Gina Pastino
  • Publication number: 20210113494
    Abstract: The present disclosure provides methods for safe and efficacious administration of esketamine.
    Type: Application
    Filed: December 29, 2020
    Publication date: April 22, 2021
    Inventors: Elena Kagan, Gina Pastino, Esther Lukasiewicz-Hagai, Ari Gershon
  • Publication number: 20200147005
    Abstract: The present invention provides a method for safe and efficacious administration of esketamine.
    Type: Application
    Filed: October 4, 2019
    Publication date: May 14, 2020
    Inventors: Elena Kagan, Gina Pastino
  • Publication number: 20200000748
    Abstract: The present invention provides a method for safe and efficacious administration of esketamine.
    Type: Application
    Filed: June 27, 2019
    Publication date: January 2, 2020
    Inventors: Elena Kagan, Petra Luise Goelzer
  • Publication number: 20170231927
    Abstract: The present invention relates to oral dosage forms comprising Memantine or a pharmaceutically acceptable salt thereof, pharmaceutical formulations comprising the oral dosage forms, and methods for treating mild, moderate or severe Alzheimer's dementia, or neuropathic pain comprising the oral dosage forms and formulations.
    Type: Application
    Filed: May 1, 2017
    Publication date: August 17, 2017
    Inventors: ELENA KAGAN, NITZAN SHAHAR, ELINA HARONSKY, GREGG R. DEROSA
  • Publication number: 20140050784
    Abstract: The present invention relates to oral dosage forms comprising Memantine or a pharmaceutically acceptable salt thereof, pharmaceutical formulations comprising the oral dosage forms, and methods for treating mild, moderate or severe Alzheimer's dementia, or neuropathic pain comprising the oral dosage forms and formulations.
    Type: Application
    Filed: August 16, 2013
    Publication date: February 20, 2014
    Applicants: TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICAL INDUSTRIES LTD.
    Inventors: Elena KAGAN, Nitzan SHAHAR, Elina HARONSKY, Gregg R. DEROSA